Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BACHEM HOLDING AG

BANB.S ✓ COMPLIANT ☆ Track — members

SIX Swiss Exchange · Healthcare · Biotechnology & Medical Research ·

Switzerland Mid Cap Analyst: HOLD

Last Close

$92.55

▲ +0.20%

Market Cap $6.94B · Vol 77.07K

Key Metrics

P/E Ratio

37.94

FWD: 27.31

Market Cap

$6.94B

Mid Cap

Div Yield

1.20%

Dividend with no set frequency

EPS Growth

+15.33%

YoY

RSI (14)

58.40

Momentum

Beta

0.61

vs Market

52W High

$102.39

13.70% below

52W Low

$59.67

53.69% above

Volume

77.07K

Avg 120.36K

P/B

3.08

Price-to-book

ROE

10.44%

Return on equity

Free Float

99.75%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BACHEM HOLDING AG (BANB.S) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BANB.S pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.17%

-0.20%

-2.02%

+17.12%

YTD

+25.63%

+9.14%

-2.10%

-37.40%

Financials & Valuation

TTM · Annual

Total Revenue	$877.28M
Net Income	$187.80M
Revenue Growth (YoY)	+4.30%
Gross Margin	28.74%
Operating Margin	24.07%
Net Profit Margin	21.41%
ROE	10.44%
ROA · ROIC	7.76% · 10.26%

P/E Ratio	37.94
Forward P/E (FY1)	27.31
PEG Ratio	1.27
P/S	6.46
P/B	3.08
P/FCF	N/A
EPS Growth	+15.33%
Outstanding Shares	75.00M

Technical Indicators

50-Day SMA	$89.20
200-Day SMA	$80.60
RSI (14)	58.40
Beta	0.61
52-Week High	$102.39
52-Week Low	$59.67

Volume Today	77.07K
Avg Daily Volume (30D)	120.36K
Relative Volume	0.64x
Volatility (10D)	18.00
Volatility (30D)	43.15
Free Float	99.75%

Analyst Consensus

HOLD

Current Price $92.55

Mean Target $98.73

52W Low$59.67 52W High$102.39

Current

Target

$59.67 $102.39

Current Analyst target

+6.68% upside potential · 11 analysts

Identifiers

ExchangeSIX Swiss Exchange

FIGIBBG001SB0092

ISINCH1176493729

CountrySwitzerland

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateMar 4, 2027

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.